Validity and Reliability of the Scale Assessment and Rating of Ataxia Persian Version Questionnaire

Document Type : Original Article

Authors

1 Ear Nose Throat Department, North Khorasan University of Medical Sciences, Bojnurd, Iran

2 Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Ferdowsi University of Mashhad, Mashhad, Iran.

5 Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

6 Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

7 Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction: The Ataxia Assessment and Rating Scale (SARA) has been validated in English and a standardized tool having translation and modification according to Iranian language and culture was needed. Therefore, we aimed to determine the validity and reliability of the SARA.
Methods: This cross-sectional study was conducted among patients with ataxia who were referred to the otolaryngology office from April 2023 to January 2024. The SARA questionnaire consists of 8 objects that have been translated into Persian. Cronbach’s alpha coefficient was measured to find the internal consistency. Moreover, the intra-class correlation coefficient (ICC) was calculated to evaluate the test-retest reliability. Furthermore, the content validity ratio (CVR) and the content validity index (CVI) were calculated to assess the content validity.
Results: A total of 11 patients with ataxia (aged 48.5±18.8 years) enrolled in the current study. After examining the face validity, the experts did not mention any particular problem. In the content validity, each CVI and CVR index item was equal to one. Cronbach's alpha obtained was equal to 0.893 that indicates a high level of internal consistency of this scale in the first iteration. In the second iteration, this index was obtained as 0.892. In all the items, except the heel shin item, the value of the ICC could not be estimated because the scores in the first and second iterations were the same. ICC for the heel shin item was equal to 0.944.
Conclusion: The Persian version of the SARA questionnaire achieved the necessary validity and reliability and can be used in patients with ataxia to detect the ataxia symptoms and its severity in the country.

Keywords


  1. Choi SW, Han N, Jung SH, Kim HD, Eom MJ, Bae HW. Evaluation of ataxia in mild ischemic stroke patients using the scale for the assessment and rating of ataxia (SARA). Annals of rehabilitation medicine. 2018 Jun 27;42(3):375-83.
  2. Mariotti C, Fancellu R, Di Donato S. An overview of the patient with ataxia. Journal of neurology. 2005 May;252:511-8.
  3. Marsden J, Harris C. Cerebellar ataxia: pathophysiology and rehabilitation. Clinical rehabilitation. 2011 Mar;25(3):195-216.
  4. Sporns O. Networks of the Brain. MIT press; 2016 Feb 12
  5. Ercoli T, Defazio G, Muroni A. Cerebellar syndrome associated with thyroid disorders. The Cerebellum. 2019 Oct;18(5):932-40.
  6. Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. Journal of Neurology. 2021 Oct 1:1-32.
  7. Pedroso JL, Vale TC, Braga-Neto P, Dutra LA, França MC, Teive HA, et al. Acute cerebellar ataxia: differential diagnosis and clinical approach. Arquivos de neuro-psiquiatria. 2019;77:184-93.
  8. Ashizawa T, Xia G. Ataxia. Continuum: Lifelong Learning in Neurology. 2016 Aug 1;22(4):1208-26.
  9. Yabe I, Matsushima M, Soma H, Basri R, Sasaki H. Usefulness of the Scale for Assessment and Rating of Ataxia (SARA). Journal of the neurological sciences. 2008 Mar 15;266(1-2):164-6.
  10. Schmitz-Hubsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006 Jun 13;66(11):1717-20.
  11. Weyer A, Abele M, Schmitz‐Hübsch T, Schoch B, Frings M, Timmann D, et al. Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients. Movement disorders: official journal of the Movement Disorder Society. 2007 Aug 15;22(11):1633-7.
  12. Salcı Y, Fil A, Keklicek H, Çetin B, Armutlu K, Dolgun A, et al. Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia. Multiple sclerosis and related disorders. 2017 Nov 1;18:135-40.
  13.  Yamauchi K, Kumagae K, Goto K, Hagiwara R, Uchida Y, Harayama E, et al. Predictive validity of the scale for the assessment and rating of ataxia for medium-term functional status in acute ataxic stroke. Journal of Stroke and Cerebrovascular Diseases. 2021 Apr 1;30(4):105631.
  14. Boyce MJ, McCambridge AB, Bradnam LV, Canning CG, Mahant N, Chang FC, et al. A cross-sectional study of walking, balance and upper limb assessment scales in people with cervical dystonia. Journal of Neural Transmission. 2021 Nov;128:1663-75.
  15. Knuijver T, Schellekens A, Belgers M, Donders R, van Oosteren T, Kramers K, et al. Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study. Addiction. 2022 Jan;117(1):118-28.
  16. Fields T, Patterson M, Bremova-Ertl T, Belcher G, Billington I, Churchill GC, et al. A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia. Trials. 2021 Dec;22:1-5.
  17. Saberi‐Karimian M, Beyraghi‐Tousi M, Jamialahmadi T, Sahebkar A. The positive short‐term effect of dexamethasone on ataxia symptoms in a patient with ataxia‐telangiectasia: A case report. Clinical Case Reports. 2022 May;10(5):e05895.
  18. Saberi-Karimian M, Houra M, Jamialahmadi T, Sarvghadi P, Nikbaf M, Akhlaghi S, et al. The effects of N-Acetyl-L-Leucine on the improvement of symptoms in a patient with multiple sulfatase deficiency. The Cerebellum. 2023 Dec;22(6):1250-6.
  19. Beyraghi-Tousi M, Sahebkar A, Houra M, Sarvghadi P, Jamialahmadi T, Bagheri R, et al. Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial. European Journal of Paediatric Neurology. 2024 May 1;50:57-63.
  20. Waltz CF, Bausell BR. Nursing research: design statistics and computer analysis. Davis Fa; 1981 Jan 1.
  21. Lawshe CH. A Quantitative Approach to Content Validity. Personnel psychology/Berrett-Koehler Publishers. 1975.
  22. Carvajal A, Centeno C, Watson R, Martínez M, Rubiales AS. How is an instrument for measuring health to be validated?. InAnales del sistema sanitario de Navarra 2011 Jan 1 (Vol. 34, No. 1, pp. 63-72).
  23. Song TA, Niu HX, Lu ZH, Yuan GA, Lu JM, Shi CH, et al. Reliability and validity of the Chinese version of the Scale for Assessment and Rating of Ataxia. Chinese medical journal. 2013 Jun 5;126(11):2045-8.
  24. Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology. 2005 Apr 12;64(7):1261-2.
  25. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the unified multiple system atrophy rating scale (UMSARS). Movement Disorders. 2004 Dec;19(12):1391-402.
  26. Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS. Movement disorders. 2009 Sep 15;24(12):1820-8.
  27. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. Journal of the neurological sciences. 1997 Feb 12;145(2):205-11.
  28. Braga-Neto P, Godeiro-Junior C, Dutra LA, Pedroso JL, Barsottini OG. Translation and validation into Brazilian version of the Scale of the Assessment and Rating of Ataxia (SARA). Arquivos de neuro-psiquiatria. 2010;68:228-30.
  29. Kim BR, Lim JH, Lee SA, Park S, Koh SE, Lee IS, et al. Usefulness of the Scale for the Assessment and Rating of Ataxia (SARA) in ataxic stroke patients. Annals of Rehabilitation Medicine. 2011 Dec 30;35(6):772-80.